PubMed=9594332; DOI=10.5555/cmj.0366-6999.110.03.p167.01
Guo H.-Q., Lu G.-C., Xiong X.-L., Dong J.-H., Liu S.-C., Zao S.-Y.
Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
Chin. Med. J. 110:167-172(1997)

PubMed=23618585; DOI=10.1016/j.juro.2013.04.053
Zhou H.-L., Zheng Y.-J., Cheng X.-Z., Lv Y.-S., Gao R., Mao H.-P., Chen Q.
Intercellular transfer of P-glycoprotein from the drug resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact.
J. Urol. 190:1069-1075(2013)

PubMed=26116706; DOI=10.1096/fj.14-266718
Ye F., Chen C.-G., Qin J., Liu J., Zheng C.-Y.
Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China.
FASEB J. 29:4268-4272(2015)

PubMed=30967374; DOI=10.1242/bio.041889
Cheng X.-Z., Zhou H.-L., Tang S.-X., Jiang T., Chen Q., Gao R., Ding Y.-L.
Intercellular transfer of P-glycoprotein mediates the formation of stable multi-drug resistance in human bladder cancer BIU-87 cells.
Biol. Open 8:bio041889.1-bio041889.6(2019)